Accuracy of anterior nasal swab rapid antigen tests compared with RT-PCR for massive SARS-CoV-2 screening in low prevalence population

被引:9
|
作者
Jakobsen, Kathrine Kronberg [1 ]
Jensen, Jakob Schmidt [1 ]
Todsen, Tobias [1 ,2 ]
Kirkby, Nikolai [3 ]
Lippert, Freddy [4 ]
Vangsted, Anne-Marie [5 ]
Klokker, Mads [1 ]
von Buchwald, Christian [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Inge Lehmanns Vej 8, DK-2100 Copenhagen, Denmark
[2] Copenhagen Acad Med Educ & Simulat, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark
[4] Univ Copenhagen, Copenhagen Emergency Med Serv, Copenhagen, Denmark
[5] Testctr Danmark, Statens Serum Inst, Copenhagen, Denmark
关键词
COVID-19; SARS-CoV-2; diagnostic testing; rapid antigen test;
D O I
10.1111/apm.13189
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim was to determine the accuracy of anterior nasal swab in rapid antigen (Ag) tests in a low SARS-CoV-2 prevalence and massive screened community. Individuals, aged 18 years or older, who self-booked an appointment for real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test in March 2021 at a public test center in Copenhagen, Denmark were included. An oropharyngeal swab was collected for RT-PCR testing, followed by a swab from the anterior parts of the nose examined by Ag test (SD Biosensor). Accuracy of the Ag test was calculated with RT-PCR as reference. We included 7074 paired conclusive tests (n = 3461, female: 50.7%). The median age was 48 years (IQR: 36-57 years). The prevalence was 0.9%, that is, 66 tests were positive on RT-PCR. Thirty-two had a paired positive Ag test. The sensitivity was 48.5% and the specificity was 100%. This study conducted in a low prevalence setting in a massive screening set-up showed that the Ag test had a sensitivity of 48.5% and a specificity of 100%, that is, no false positive tests. The lower sensitivity is a challenge especially if Ag testing is not repeated frequently allowing this scalable test to be a robust supplement to RT-PCR testing in an ambitious public SARS-CoV-2 screening.
引用
收藏
页码:95 / 100
页数:6
相关论文
共 50 条
  • [41] Development of a rapid viability RT-PCR assay for detection of infectious SARS-CoV-2
    Veugen, J. M. J.
    Schoenmakers, T.
    van Loo, I. H. M.
    Haagmans, B. L.
    Leers, M. P. G.
    Nuijts, R. M. M. A.
    Savelkoul, P. H. M.
    Wolffs, P. F. G.
    Dickman, M. M.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 4 - 4
  • [42] Confirming rapid test diagnostics in SARS-CoV-2 infections using RT-PCR
    Cristea, Rodica Madalina
    Apostol, Pompilia Petruta
    Ivan, Madalina Andreea
    Pelin, Maria
    Robert, Nitu Florin
    Nitu, Robert Adrian
    Csutak, Ortansa
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 607 - 607
  • [43] Development of a rapid viability RT-PCR assay for detection of infectious SARS-CoV-2
    Veugen, Judith
    Schoenmakers, Tom
    van Loo, Inge
    Leers, Mathie
    Nuijts, Rudy
    Savelkoul, Paul
    Dickman, Mor
    Wolffs, Petra
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [44] Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants
    Migueres, M.
    Lhomme, S.
    Tremeaux, P.
    Dimeglio, C.
    Ranger, N.
    Latour, J.
    Dubois, M.
    Nicot, F.
    Miedouge, M.
    Mansuy, J. M.
    Izopet, J.
    JOURNAL OF CLINICAL VIROLOGY, 2021, 143
  • [45] SARS-CoV-2 RT-PCR as a universal screening on planned admission in asymptomatic patients
    Yamamoto, Chie
    Nukui, Yoko
    Furukawa, Keitaro
    Taniguchi, Masashi
    Yamano, Tetsuhiro
    Inaba, Tohru
    Kikai, Rie
    Tanino, Yoko
    Yamada, Yukiji
    Teramukai, Satoshi
    Takayama, Koichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (07) : 668 - 671
  • [46] Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR
    Ioanna Smyrlaki
    Martin Ekman
    Antonio Lentini
    Nuno Rufino de Sousa
    Natali Papanicolaou
    Martin Vondracek
    Johan Aarum
    Hamzah Safari
    Shaman Muradrasoli
    Antonio Gigliotti Rothfuchs
    Jan Albert
    Björn Högberg
    Björn Reinius
    Nature Communications, 11
  • [47] Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR
    Smyrlaki, Ioanna
    Ekman, Martin
    Lentini, Antonio
    de Sousa, Nuno Rufino
    Papanicolaou, Natali
    Vondracek, Martin
    Aarum, Johan
    Safari, Hamzah
    Muradrasoli, Shaman
    Rothfuchs, Antonio Gigliotti
    Albert, Jan
    Hoegberg, Bjoern
    Reinius, Bjoern
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [48] Predictors of SARS-CoV-2 Positivity Based on RT-PCR Swab Tests at a Drive-Through Outpatient Clinic for COVID-19 Screening in Japan
    Ishii, Tadashi
    Kushimoto, Shigeki
    Katori, Yukio
    Kure, Shigeo
    Igarashi, Kaoru
    Fujita, Motoo
    Takayama, Shin
    Abe, Michiaki
    Tanaka, Junichi
    Kikuchi, Akiko
    Abe, Yoshiko
    Imai, Hiroyuki
    Inaba, Yohei
    Iwamatsu-Kobayashi, Yoko
    Nishioka, Takashi
    Onodera, Ko
    Akaishi, Tetsuya
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 253 (02): : 101 - 108
  • [49] Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2
    Nomoto, Hidetoshi
    Yamamoto, Kei
    Isaka, Erina
    Miyazato, Yusuke
    Suzuki, Tetsuya
    Maruki, Taketomo
    Yamada, Gen
    Kamegai, Kohei
    Akiyama, Yutaro
    Ide, Satoshi
    Kurokawa, Masami
    Moriya, Ataru
    Mezaki, Kazuhisa
    Yagi, Shintaro
    Nojima, Hisashi
    Yamakawa, Kentaro
    Ohmagari, Norio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (01) : 15 - 19
  • [50] Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population
    Tu, Yuan-Po
    Iqbal, Jameel
    O'Leary, Timothy
    ELIFE, 2021, 10